Brii Biosciences Limited (BRIBF)
OTCMKTS
· Delayed Price · Currency is USD
0.3042
+0.0042 (1.40%)
At close: Mar 31, 2025
Brii Biosciences Market Cap
Brii Biosciences has a market cap or net worth of $182.65 million as of April 28, 2025. Its market cap has increased by 115.28% in one year.
Market Cap
182.65M
Enterprise Value
-140.51M
Revenue
7.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.30
Market Cap Chart
Since July 13, 2021, Brii Biosciences's market cap has decreased from 2.09B to 182.65M, a decrease of -91.25%. That is a compound annual growth rate of -47.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 185.43M | 100.97% |
| Dec 31, 2024 | 92.26M | -56.66% |
| Dec 29, 2023 | 212.88M | -69.02% |
| Dec 30, 2022 | 687.16M | -77.39% |
| Dec 31, 2021 | 3.04B | 45.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.63B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 746.57M |
| Glass House Brands | 469.11M |
| Northwest Biotherapeutics | 443.51M |
| Elite Pharmaceuticals | 439.57M |
| CytoDyn | 284.08M |
| BioStem Technologies | 242.70M |